JPRN-UMIN000046994尚未招募未知
Effect of oral semaglutide on hepatic fibrosis of type 2 diabetes patients with NAFLD - Effect of oral semaglutide on hepatic fibrosis of type 2 diabetes patients with NAFLD
Shizuoka General Hospital, Center for Diabetes, Endocrinology and Metabolism0 个研究点目标入组 50 人开始时间: 2022年3月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Diabetes other than type 2 diabetes (2) Taking thiazolidine drugs (3) History of use of other GLP-1 receptor agonists (4) Patients diagnosed with liver diseases other than NAFLD such as viral hepatitis and autoimmune hepatitis (5) Allergies to semaglutide (6) Diabetic ketoacidosis, diabetic coma or precoma, type 1 diabetes (7) Serious conditions such as acute infections and surgery (8) Patients judged to be inappropriate
研究者
相似试验
尚未招募
Unknown
The effect of semaglutide on liver function in NAFLD patietns with DMAFLDJPRN-UMIN000046309Kyoto Prefectural University of Medicine50
进行中（未招募）
1 期
The effect of semaglutide therapy on hepatic fat content and on the acute response of liver fat to high-fat loadMedDRA version: 20.0Level: PTClassification code: 10029883Term: Obesity Class: 100000004861ObesityCTIS2023-504988-16-00Institut Klinicke A Experimentalni Mediciny16
招募中
3 期
The effect of semaglutide in non-cirrhotic non-alcoholic steatohepatitisnon-alcoholic steatohepatitisnon-alcoholic liver inflammation10019654NL-OMON54111ovo Nordisk10
招募中
不适用
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes MellitusDiabete MellitusLiver Transplant ComplicationsNCT06060392Medanta, The Medicity, India50
尚未招募
不适用
Analysis of the inhibition of liver fibrosis by interferon beta administratiochronic hepatitis and liver cirrhosis type CJPRN-UMIN000005746Center for genomic medicine, Kyoto University50